HDAC10 Inhibits Cervical Cancer Progression through Downregulating the HDAC10-microRNA-223-EPB41L3 Axis

Figure 6

miR-223 targets EPB41L3 in cervical cancer. (a) Analysis of the binding site of miR-223 and EPB41L3 by using TargetScan software. (b) Analysis of the correlation between miR-223 and EPB41L3. (c) Assessment of the binding relation between miR-223 and EPB41L3 using the dual-luciferase reporter gene experiment. (d) Expression level of EPB41L3 in cervical cancer cells after miR-223 expression regulation. (e) Expression of EPB41L3 in tumor and normal tissues based on the CESC-TCGA database.

(a)

(b)

(c)

(d)

(e)